{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:34:20Z","timestamp":1791135260858,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6874-14-93","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T11:02:12Z","timestamp":1407236532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review"],"prefix":"10.1186","volume":"14","author":[{"given":"Xinghua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chigang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004, 89: 2745-2749.","journal-title":"J Clin Endocrinol Metab"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2265.2011.04194.x","volume":"76","author":"X Xu","year":"2012","unstructured":"Xu X, Shi Y, Cui Y, Ma J, Che L, Chen ZJ: Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes. Clin Endocrinol (Oxf). 2012, 76: 425-430.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1477-7827-9-76","volume":"9","author":"X Xu","year":"2011","unstructured":"Xu X, Zhao H, Shi Y, You L, Bian Y, Zhao Y, Chen ZJ: Family association study between INSR gene polymorphisms and PCOS in Han Chinese. Reprod Biol Endocrinol. 2011, 9: 76.","journal-title":"Reprod Biol Endocrinol"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10815-013-0111-1","volume":"30","author":"VR Tumu","year":"2013","unstructured":"Tumu VR, Govatati S, Guruvaiah P, Deenadayal M, Shivaji S, Bhanoori M: An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women. J Assist Reprod Genet. 2013, 30: 1541-1546.","journal-title":"J Assist Reprod Genet"},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/eje.0.1500525","volume":"150","author":"M Mohlig","year":"2004","unstructured":"Mohlig M, Spranger J, Osterhoff M, Ristow M, Pfeiffer AF, Schill T, Schlosser HW, Brabant G, Schofl C: The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur J Endocrinol. 2004, 150: 525-532.","journal-title":"Eur J Endocrinol"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1600-0897.2011.01059.x","volume":"66","author":"YS Lin","year":"2011","unstructured":"Lin YS, Tsai SJ, Lin MW, Yang CT, Huang MF, Wu MH: Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor substrate-2 polymorphism. Am J Reprod Immunol. 2011, 66: 527-533.","journal-title":"Am J Reprod Immunol"},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/oby.2003.136","volume":"11","author":"HF Escobar-Morreale","year":"2003","unstructured":"Escobar-Morreale HF, Calvo RM, Villuendas G, Sancho J, San Millan JL: Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res. 2003, 11: 987-996.","journal-title":"Obes Res"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s12020-012-9728-6","volume":"42","author":"F Gonzalez","year":"2012","unstructured":"Gonzalez F, Sia CL, Stanczyk FZ, Blair HE, Krupa ME: Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. Endocrine. 2012, 42: 726-735.","journal-title":"Endocrine"},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1196\/annals.1365.015","volume":"1092","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Paterakis T, Kandarakis HA: Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci. 2006, 1092: 175-186.","journal-title":"Ann N Y Acad Sci"},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ncpendmet0787","volume":"4","author":"A Dunaif","year":"2008","unstructured":"Dunaif A: Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome\u2013a reappraisal. Nat Clin Pract Endocrinol Metab. 2008, 4: 272-283.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans SM, Pate KA: Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013, 6: 1-13.","journal-title":"Clin Epidemiol"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humupd\/dmr042","volume":"18","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF, Norman RJ: Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012, 18: 146-170.","journal-title":"Hum Reprod Update"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"EA-SP Rotterdam","year":"2004","unstructured":"Rotterdam EA-SP: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19: 41-47.","journal-title":"Hum Reprod"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.fertnstert.2005.01.085","volume":"83","author":"R Azziz","year":"2005","unstructured":"Azziz R: Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril. 2005, 83: 1343-1346.","journal-title":"Fertil Steril"},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jc.2004-1405","volume":"90","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, de Zegher F: Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. J Clin Endocrinol Metab. 2005, 90: 39-43.","journal-title":"J Clin Endocrinol Metab"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1055\/s-0030-1262855","volume":"42","author":"M Luque-Ramirez","year":"2010","unstructured":"Luque-Ramirez M, Escobar-Morreale HF: Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations. Horm Metab Res. 2010, 42: 815-820.","journal-title":"Horm Metab Res"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/09513590802128968","volume":"24","author":"J Jakubowska","year":"2008","unstructured":"Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A, Szymczak J, Bednarek-Tupikowska G, Demissie M: Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecol Endocrinol. 2008, 24: 378-384.","journal-title":"Gynecol Endocrinol"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.metabol.2013.07.004","volume":"62","author":"TP Ciaraldi","year":"2013","unstructured":"Ciaraldi TP, Aroda V, Mudaliar SR, Henry RR: Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: Effects of pioglitazone and metformin treatment. Metabolism. 2013, 62: 1587-1596.","journal-title":"Metabolism"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.2174\/1381612811319320012","volume":"19","author":"M Ojeda-Ojeda","year":"2013","unstructured":"Ojeda-Ojeda M, Murri M, Insenser M, Escobar-Morreale HF: Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS). Curr Pharm Des. 2013, 19: 5775-5791.","journal-title":"Curr Pharm Des"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/jc.2004-0463","volume":"89","author":"L Ibanez","year":"2004","unstructured":"Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, De Zegher F: Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab. 2004, 89: 4331-4337.","journal-title":"J Clin Endocrinol Metab"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000348497","volume":"75","author":"E Gozdemir","year":"2013","unstructured":"Gozdemir E, Kaygusuz I, Kafali H: Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome?. Gynecol Obstet Invest. 2013, 75: 196-202.","journal-title":"Gynecol Obstet Invest"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-14-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-14-93\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-14-93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-14-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T09:03:40Z","timestamp":1548234220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-14-93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-14-93","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]},"assertion":[{"value":"13 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"93"}}